A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Novartis Ag stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 200 shares of NVS stock, worth $19,820. This represents 0.01% of its overall portfolio holdings.

Number of Shares
200
Previous 200 -0.0%
Holding current value
$19,820
Previous $21,000 9.52%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$95.27 - $108.47 $3,143 - $3,579
-33 Reduced 14.16%
200 $19,000
Q4 2023

Jan 31, 2024

SELL
$92.27 - $101.54 $4,152 - $4,569
-45 Reduced 16.19%
233 $23,000
Q3 2023

Nov 09, 2023

BUY
$94.73 - $105.13 $9,283 - $10,302
98 Added 54.44%
278 $28,000
Q1 2022

Jun 17, 2022

BUY
$80.11 - $90.62 $14,419 - $16,311
180 New
180 $16,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $213B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Oliver Lagore Vanvalin Investment Group Portfolio

Follow Oliver Lagore Vanvalin Investment Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oliver Lagore Vanvalin Investment Group, based on Form 13F filings with the SEC.

News

Stay updated on Oliver Lagore Vanvalin Investment Group with notifications on news.